Ann M. Hesketh

Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide

Paul J. Hesketh, David R. Gandara, Ann M. Hesketh et al. · Supportive Care in Cancer · 1996 · 33 citations

Antiemetic Efficacy, Medicine, Metronomic Therapy +8

Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy

Paul J. Hesketh, Pedro Sanz-Altamira, Julie A. Bushey et al. · Supportive Care in Cancer · 2011 · 24 citations

Oncology, Gastrointestinal Oncology, Gastroenterology +7

Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide

Paul J. Hesketh, Jerry Younger, Pedro Sanz-Altamira et al. · Supportive Care in Cancer · 2008 · 19 citations

Breast Oncology, Oncology, Breast Cancer Patients +7

Treatment of advanced non‐small cell lung cancer with cisplatin, 5‐fluorouracil, and mitomycin C

Paul J. Hesketh, Timothy P. Cooley, Harvey E. Finkel et al. · Cancer · 1988 · 18 citations

Mitomycin C, Thirty Patients, Pathology +17